ERBB2 and gastric cancer: Up to now, the first-line treatment for advanced gastric cancer (AGC) or metastatic gastric cancer (MGC) with HER2-negative in Asia is either doublet regimen of S-1 or Capecitabine plus Cisplatin or Oxaliplatin (3).